Malcolm Weir

Heptares Therapeutics Ltd. designs and develops new medicines targeting G protein-coupled receptors. It builts an exciting discovery and development pipeline of novel drug candidates, which have the potential to transform the treatment of serious diseases, including alzheimer's disease, parkinson's disease, schizophrenia, migraine and diabetes. The company was founded by Richard Henderson, Fiona Hamilton Marshall, Ludwig Michael Steinmetz, Christopher G. Tate and Malcolm Weir in 2007 and is headquartered in Welwyn Garden City, the United Kingdom.

The Biochemical Society conducts research in various areas of molecular biosciences, including biological clocks, gene therapy, embryogenesis, and more. The non-profit company is based in London, UK, and has subsidiaries in the United Kingdom. The British company also provides public engagement and outreach resources and offer grants, prizes, and support to science communicators.

The Biochemical Society conducts research in various areas of molecular biosciences, including biological clocks, gene therapy, embryogenesis, and more. The non-profit company is based in London, UK, and has subsidiaries in the United Kingdom. The British company also provides public engagement and outreach resources and offer grants, prizes, and support to science communicators.

The Biochemical Society conducts research in various areas of molecular biosciences, including biological clocks, gene therapy, embryogenesis, and more. The non-profit company is based in London, UK, and has subsidiaries in the United Kingdom. The British company also provides public engagement and outreach resources and offer grants, prizes, and support to science communicators.

The Biochemical Society conducts research in various areas of molecular biosciences, including biological clocks, gene therapy, embryogenesis, and more. The non-profit company is based in London, UK, and has subsidiaries in the United Kingdom. The British company also provides public engagement and outreach resources and offer grants, prizes, and support to science communicators.

The Biochemical Society conducts research in various areas of molecular biosciences, including biological clocks, gene therapy, embryogenesis, and more. The non-profit company is based in London, UK, and has subsidiaries in the United Kingdom. The British company also provides public engagement and outreach resources and offer grants, prizes, and support to science communicators.

The Biochemical Society conducts research in various areas of molecular biosciences, including biological clocks, gene therapy, embryogenesis, and more. The non-profit company is based in London, UK, and has subsidiaries in the United Kingdom. The British company also provides public engagement and outreach resources and offer grants, prizes, and support to science communicators.

The Biochemical Society conducts research in various areas of molecular biosciences, including biological clocks, gene therapy, embryogenesis, and more. The non-profit company is based in London, UK, and has subsidiaries in the United Kingdom. The British company also provides public engagement and outreach resources and offer grants, prizes, and support to science communicators.

Heptares Therapeutics Ltd. designs and develops new medicines targeting G protein-coupled receptors. It builts an exciting discovery and development pipeline of novel drug candidates, which have the potential to transform the treatment of serious diseases, including alzheimer's disease, parkinson's disease, schizophrenia, migraine and diabetes. The company was founded by Richard Henderson, Fiona Hamilton Marshall, Ludwig Michael Steinmetz, Christopher G. Tate and Malcolm Weir in 2007 and is headquartered in Welwyn Garden City, the United Kingdom.

The Biochemical Society conducts research in various areas of molecular biosciences, including biological clocks, gene therapy, embryogenesis, and more. The non-profit company is based in London, UK, and has subsidiaries in the United Kingdom. The British company also provides public engagement and outreach resources and offer grants, prizes, and support to science communicators.

The Biochemical Society conducts research in various areas of molecular biosciences, including biological clocks, gene therapy, embryogenesis, and more. The non-profit company is based in London, UK, and has subsidiaries in the United Kingdom. The British company also provides public engagement and outreach resources and offer grants, prizes, and support to science communicators.

The Biochemical Society conducts research in various areas of molecular biosciences, including biological clocks, gene therapy, embryogenesis, and more. The non-profit company is based in London, UK, and has subsidiaries in the United Kingdom. The British company also provides public engagement and outreach resources and offer grants, prizes, and support to science communicators.

Heptares Therapeutics Ltd. designs and develops new medicines targeting G protein-coupled receptors. It builts an exciting discovery and development pipeline of novel drug candidates, which have the potential to transform the treatment of serious diseases, including alzheimer's disease, parkinson's disease, schizophrenia, migraine and diabetes. The company was founded by Richard Henderson, Fiona Hamilton Marshall, Ludwig Michael Steinmetz, Christopher G. Tate and Malcolm Weir in 2007 and is headquartered in Welwyn Garden City, the United Kingdom.

The Biochemical Society conducts research in various areas of molecular biosciences, including biological clocks, gene therapy, embryogenesis, and more. The non-profit company is based in London, UK, and has subsidiaries in the United Kingdom. The British company also provides public engagement and outreach resources and offer grants, prizes, and support to science communicators.

Heptares Therapeutics Ltd. designs and develops new medicines targeting G protein-coupled receptors. It builts an exciting discovery and development pipeline of novel drug candidates, which have the potential to transform the treatment of serious diseases, including alzheimer's disease, parkinson's disease, schizophrenia, migraine and diabetes. The company was founded by Richard Henderson, Fiona Hamilton Marshall, Ludwig Michael Steinmetz, Christopher G. Tate and Malcolm Weir in 2007 and is headquartered in Welwyn Garden City, the United Kingdom.

The Biochemical Society conducts research in various areas of molecular biosciences, including biological clocks, gene therapy, embryogenesis, and more. The non-profit company is based in London, UK, and has subsidiaries in the United Kingdom. The British company also provides public engagement and outreach resources and offer grants, prizes, and support to science communicators.

Heptares Therapeutics Ltd. designs and develops new medicines targeting G protein-coupled receptors. It builts an exciting discovery and development pipeline of novel drug candidates, which have the potential to transform the treatment of serious diseases, including alzheimer's disease, parkinson's disease, schizophrenia, migraine and diabetes. The company was founded by Richard Henderson, Fiona Hamilton Marshall, Ludwig Michael Steinmetz, Christopher G. Tate and Malcolm Weir in 2007 and is headquartered in Welwyn Garden City, the United Kingdom.

Heptares Therapeutics Ltd. designs and develops new medicines targeting G protein-coupled receptors. It builts an exciting discovery and development pipeline of novel drug candidates, which have the potential to transform the treatment of serious diseases, including alzheimer's disease, parkinson's disease, schizophrenia, migraine and diabetes. The company was founded by Richard Henderson, Fiona Hamilton Marshall, Ludwig Michael Steinmetz, Christopher G. Tate and Malcolm Weir in 2007 and is headquartered in Welwyn Garden City, the United Kingdom.